{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:43:24Z","timestamp":1793825004451,"version":"4.6.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008947","name":"Stiftung Synapsis - Alzheimer Forschung Schweiz AFS","doi-asserted-by":"publisher","award":["2017-PI01"],"award-info":[{"award-number":["2017-PI01"]}],"id":[{"id":"10.13039\/501100008947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["SNF 320030_141179"],"award-info":[{"award-number":["SNF 320030_141179"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple pathophysiological processes have been described in Alzheimer\u2019s disease (AD). Their inter-individual variations, complex interrelations, and relevance for clinical manifestation and disease progression remain poorly understood. We hypothesize that specific molecular patterns indicating both known and yet unidentified pathway alterations are associated with distinct aspects of AD pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed multi-level cerebrospinal fluid (CSF) omics in a well-characterized cohort of older adults with normal cognition, mild cognitive impairment, and mild dementia. Proteomics, metabolomics, lipidomics, one-carbon metabolism, and neuroinflammation related molecules were analyzed at single-omic level with correlation and regression approaches. Multi-omics factor analysis was used to integrate all biological levels. Identified analytes were used to construct best predictive models of the presence of AD pathology and of cognitive decline with multifactorial regression analysis. Pathway enrichment analysis identified pathway alterations in AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multi-omics integration identified five major dimensions of heterogeneity explaining the variance within the cohort and differentially associated with AD. Further analysis exposed multiple interactions between single \u2018omics modalities and distinct multi-omics molecular signatures differentially related to amyloid pathology, neuronal injury, and tau hyperphosphorylation. Enrichment pathway analysis revealed overrepresentation of the hemostasis, immune response, and extracellular matrix signaling pathways in association with AD. Finally, combinations of four molecules improved prediction of both AD (protein 14-3-3 zeta\/delta, clusterin, interleukin-15, and transgelin-2) and cognitive decline (protein 14-3-3 zeta\/delta, clusterin, cholesteryl ester 27:1 16:0 and monocyte chemoattractant protein-1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Applying an integrative multi-omics approach we report novel molecular and pathways alterations associated with AD pathology. These findings are relevant for the development of personalized diagnosis and treatment approaches in AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-021-00814-7","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T05:03:19Z","timestamp":1617253399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Christopher","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Dayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Masoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene L.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0068-0312","authenticated-orcid":false,"given":"Julius","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"814_CR1","doi-asserted-by":"crossref","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157-72.","DOI":"10.1038\/s41582-020-00435-y"},{"issue":"7","key":"814_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jalz.2017.01.008","volume":"13","author":"MW Wong","year":"2017","unstructured":"Wong MW, Braidy N, Poljak A, Pickford R, Thambisetty M, Sachdev PS. Dysregulation of lipids in Alzheimer\u2019s disease and their role as potential biomarkers. Alzheimers Dement. 2017;13(7):810\u201327. https:\/\/doi.org\/10.1016\/j.jalz.2017.01.008.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"814_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13195-017-0270-x","volume":"9","author":"L Dayon","year":"2017","unstructured":"Dayon L, Guiraud SP, Corthesy J, Da Silva L, Migliavacca E, Tautvydaite D, et al. One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond. Alzheimers Res Ther. 2017;9(1):43. https:\/\/doi.org\/10.1186\/s13195-017-0270-x.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"814_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.dadm.2017.07.006","volume":"8","author":"FA de Leeuw","year":"2017","unstructured":"de Leeuw FA, Peeters CFW, Kester MI, Harms AC, Struys EA, Hankemeier T, et al. Blood-based metabolic signatures in Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2017;8(1):196\u2013207. https:\/\/doi.org\/10.1016\/j.dadm.2017.07.006.","journal-title":"Alzheimers Dement (Amst)"},{"key":"814_CR5","doi-asserted-by":"publisher","first-page":"530219","DOI":"10.3389\/fnins.2020.530219","volume":"14","author":"X Yan","year":"2020","unstructured":"Yan X, Hu Y, Wang B, Wang S, Zhang X. Metabolic dysregulation contributes to the progression of Alzheimer\u2019s disease. Front Neurosci. 2020;14:530219. https:\/\/doi.org\/10.3389\/fnins.2020.530219.","journal-title":"Front Neurosci"},{"key":"814_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinbiochem.2018.06.011","volume":"59","author":"GM Sancesario","year":"2018","unstructured":"Sancesario GM, Bernardini S. Alzheimer\u2019s disease in the omics era. Clin Biochem. 2018;59:9\u201316. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.06.011.","journal-title":"Clin Biochem"},{"issue":"3","key":"814_CR7","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1021\/acs.jproteome.8b00809","volume":"18","author":"L Dayon","year":"2019","unstructured":"Dayon L, Cominetti O, Wojcik J, Galindo AN, Oikonomidi A, Henry H, Migliavacca E, Kussmann M, Bowman GL, Popp J. Proteomes of paired human cerebrospinal fluid and plasma: relation to blood-brain barrier permeability in older adults. J Proteome Res. 2019;18(3):1162\u201374. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00809.","journal-title":"J Proteome Res"},{"issue":"1","key":"814_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13195-019-0551-7","volume":"11","author":"V van der Velpen","year":"2019","unstructured":"van der Velpen V, Teav T, Gallart-Ayala H, Mehl F, Konz I, Clark C, Oikonomidi A, Peyratout G, Henry H, Delorenzi M, Ivanisevic J, Popp J. Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11(1):93. https:\/\/doi.org\/10.1186\/s13195-019-0551-7.","journal-title":"Alzheimers Res Ther"},{"key":"814_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fgene.2017.00084","volume":"8","author":"S Huang","year":"2017","unstructured":"Huang S, Chaudhary K, Garmire LX. More is better: recent progress in multi-omics data integration methods. Front Genet. 2017;8:84. https:\/\/doi.org\/10.3389\/fgene.2017.00084.","journal-title":"Front Genet"},{"issue":"3","key":"814_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229922","volume":"15","author":"M-W Su","year":"2020","unstructured":"Su M-W, Chang C-K, Lin C-W, Ling S-J, Hsiung C-N, Chu H-W, Wu PE, Shen CY. Blood multiomics reveal insights into population clusters with low prevalence of diabetes, dyslipidemia and hypertension. PLoS One. 2020;15(3):e0229922. https:\/\/doi.org\/10.1371\/journal.pone.0229922.","journal-title":"PLoS One"},{"key":"814_CR11","doi-asserted-by":"crossref","unstructured":"Chalikiopoulou C, Jenko Bizjan B, Leventopoulos G, Smaili K, Blagus T, Menti A, et al. Multiomics analysis coupled with text mining identify novel biomarker candidates for recurrent cardiovascular events. OMICS. 2020;24(4):205-15.","DOI":"10.1089\/omi.2019.0216"},{"issue":"3","key":"814_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1161\/CIRCRESAHA.119.315179","volume":"126","author":"B Wang","year":"2020","unstructured":"Wang B, Lunetta KL, Dupuis J, Lubitz SA, Trinquart L, Yao L, Ellinor PT, Benjamin EJ, Lin H. Integrative omics approach to identifying genes associated with atrial fibrillation. Circ Res. 2020;126(3):350\u201360. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315179.","journal-title":"Circ Res"},{"key":"814_CR13","doi-asserted-by":"crossref","unstructured":"Badhwar A, McFall GP, Sapkota S, Black SE, Chertkow H, Duchesne S, et al. A multiomics approach to heterogeneity in Alzheimer\u2019s disease: focused review and roadmap. Brain. 2020;143(5):1315-31.","DOI":"10.1093\/brain\/awz384"},{"issue":"6","key":"814_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20178124","volume":"14","author":"R Argelaguet","year":"2018","unstructured":"Argelaguet R, Velten B, Arnol D, Dietrich S, Zenz T, Marioni JC, Buettner F, Huber W, Stegle O. Multi-omics factor analysis-a framework for unsupervised integration of multi-omics data sets. Mol Syst Biol. 2018;14(6):e8124. https:\/\/doi.org\/10.15252\/msb.20178124.","journal-title":"Mol Syst Biol"},{"key":"814_CR15","doi-asserted-by":"crossref","unstructured":"Mirza B, Wang W, Wang J, Choi H, Chung NC, Ping P. Machine learning and integrative analysis of biomedical big data. Genes 2019;10(2):87.","DOI":"10.3390\/genes10020087"},{"issue":"1","key":"814_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13059-020-02015-1","volume":"21","author":"R Argelaguet","year":"2020","unstructured":"Argelaguet R, Arnol D, Bredikhin D, Deloro Y, Velten B, Marioni JC, Stegle O. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 2020;21(1):111. https:\/\/doi.org\/10.1186\/s13059-020-02015-1.","journal-title":"Genome Biol"},{"issue":"3","key":"814_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state. J Psychiatr Res. 1975;12(3):189\u201398 Available from: URL: https:\/\/pubmed.ncbi.nlm.nih.gov\/1202204\/.","journal-title":"J Psychiatr Res"},{"issue":"11","key":"814_CR18","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134. https:\/\/doi.org\/10.1212\/WNL.43.11.2412-a.","journal-title":"Neurology"},{"key":"814_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jpsychires.2016.12.024","volume":"90","author":"D Tautvydaite","year":"2017","unstructured":"Tautvydaite D, Antonietti JP, Henry H, von Gunten A, Popp J. Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology. J Psychiatr Res. 2017;90:12\u201320. https:\/\/doi.org\/10.1016\/j.jpsychires.2016.12.024.","journal-title":"J Psychiatr Res"},{"key":"814_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/978-1-4939-7057-5_30","volume":"1619","author":"L Dayon","year":"2017","unstructured":"Dayon L, N\u00fa\u00f1ez Galindo A, Cominetti O, Corth\u00e9sy J, Kussmann M. A highly automated shotgun proteomic workflow: clinical scale and robustness for biomarker discovery in blood. Methods Mol Biol. 2017;1619:433\u201349.","journal-title":"Methods Mol Biol"},{"issue":"8","key":"814_CR21","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1021\/pr500635f","volume":"13","author":"L Dayon","year":"2014","unstructured":"Dayon L, N\u00fa\u00f1ez Galindo A, Corth\u00e9sy J, Cominetti O, Kussmann M. Comprehensive and scalable highly automated MS-based proteomic workflow for clinical biomarker discovery in human plasma. J Proteome Res. 2014;13(8):3837\u201345. https:\/\/doi.org\/10.1021\/pr500635f.","journal-title":"J Proteome Res"},{"key":"814_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-61779-885-6_9","volume":"893","author":"L Dayon","year":"2012","unstructured":"Dayon L, Sanchez J-C. Relative protein quantification by MS\/MS using the tandem mass tag technology. Methods Mol Biol. 2012;893:115\u201327. https:\/\/doi.org\/10.1007\/978-1-61779-885-6_9.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"814_CR23","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3233\/JAD-170426","volume":"60","author":"L Dayon","year":"2017","unstructured":"Dayon L, Wojcik J, Nunez Galindo A, Corthesy J, Cominetti O, Oikonomidi A, et al. Plasma proteomic profiles of cerebrospinal fluid-defined Alzheimer\u2019s disease pathology in older adults. J Alzheimers Dis. 2017;60(4):1641\u201352. https:\/\/doi.org\/10.3233\/JAD-170426.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"814_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13195-018-0397-4","volume":"10","author":"L Dayon","year":"2018","unstructured":"Dayon L, Nunez Galindo A, Wojcik J, Cominetti O, Corthesy J, Oikonomidi A, et al. Alzheimer disease pathology and the cerebrospinal fluid proteome. Alzheimers Res Ther. 2018;10(1):66. https:\/\/doi.org\/10.1186\/s13195-018-0397-4.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"814_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/JAD-170602","volume":"62","author":"BM Bettcher","year":"2018","unstructured":"Bettcher BM, Johnson SC, Fitch R, Casaletto KB, Heffernan KS, Asthana S, Zetterberg H, Blennow K, Carlsson CM, Neuhaus J, Bendlin BB, Kramer JH. Cerebrospinal fluid and plasma levels of inflammation differentially relate to CNS markers of Alzheimer\u2019s disease pathology and neuronal damage. J Alzheimers Dis. 2018;62(1):385\u201397. https:\/\/doi.org\/10.3233\/JAD-170602.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"814_CR26","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ejlt.201500145","volume":"117","author":"MA Surma","year":"2015","unstructured":"Surma MA, Herzog R, Vasilj A, Klose C, Christinat N, Morin-Rivron D, Simons K, Masoodi M, Sampaio JL. An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids. Eur J Lipid Sci Technol. 2015;117(10):1540\u20139. https:\/\/doi.org\/10.1002\/ejlt.201500145.","journal-title":"Eur J Lipid Sci Technol"},{"issue":"1","key":"814_CR27","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/s41598-017-19059-2","volume":"8","author":"M Lauria","year":"2018","unstructured":"Lauria M, Persico M, Dordevic N, Cominetti O, Matone A, Hosking J, Jeffery A, Pinkney J, da Silva L, Priami C, Montoliu I, Martin FP. Consensus clustering of temporal profiles for the identification of metabolic markers of pre-diabetes in childhood (EarlyBird 73). Sci Rep. 2018;8(1):1393. https:\/\/doi.org\/10.1038\/s41598-017-19059-2.","journal-title":"Sci Rep"},{"issue":"1","key":"814_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00216-016-0003-1","volume":"409","author":"SP Guiraud","year":"2017","unstructured":"Guiraud SP, Montoliu I, Da Silva L, Dayon L, Galindo AN, Corthesy J, et al. High-throughput and simultaneous quantitative analysis of homocysteine-methionine cycle metabolites and co-factors in blood plasma and cerebrospinal fluid by isotope dilution LC-MS\/MS. Anal Bioanal Chem. 2017;409(1):295\u2013305. https:\/\/doi.org\/10.1007\/s00216-016-0003-1.","journal-title":"Anal Bioanal Chem"},{"issue":"12","key":"814_CR29","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jalz.2018.06.2857","volume":"14","author":"GL Bowman","year":"2018","unstructured":"Bowman GL, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin IC, Henry H, Oikonomidi A, Migliavacca E, Bacher M, Popp J. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement. 2018;14(12):1640\u201350. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.2857.","journal-title":"Alzheimers Dement"},{"key":"814_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbi.2017.01.020","volume":"62","author":"J Popp","year":"2017","unstructured":"Popp J, Oikonomidi A, Tautvydaite D, Dayon L, Bacher M, Migliavacca E, et al. Markers of neuroinflammation associated with Alzheimer\u2019s disease pathology in older adults. Brain Behav Immun. 2017;62:203\u201311. https:\/\/doi.org\/10.1016\/j.bbi.2017.01.020.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"814_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-170335","volume":"60","author":"A Oikonomidi","year":"2017","unstructured":"Oikonomidi A, Tautvydaite D, Gholamrezaee MM, Henry H, Bacher M, Popp J. Macrophage migration inhibitory factor is associated with biomarkers of Alzheimer\u2019s disease pathology and predicts cognitive decline in mild cognitive impairment and mild dementia. J Alzheimers Dis. 2017;60(1):273\u201381. https:\/\/doi.org\/10.3233\/JAD-170335.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"814_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/jnc.13766","volume":"139","author":"A Oikonomidi","year":"2016","unstructured":"Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A, Popp J. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. J Neurochem. 2016;139(2):324\u201332. https:\/\/doi.org\/10.1111\/jnc.13766.","journal-title":"J Neurochem"},{"key":"814_CR33","doi-asserted-by":"crossref","unstructured":"Chakrabarti A, Eiden M, Morin-Rivron D, Christinat N, Monteiro JP, Kaput J, et al. Impact of multi-micronutrient supplementation on lipidemia of children and adolescents. Clin Nutr. 2020;39(7):2211-9.","DOI":"10.1016\/j.clnu.2019.09.010"},{"key":"814_CR34","doi-asserted-by":"crossref","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1-22.","DOI":"10.18637\/jss.v033.i01"},{"key":"814_CR35","doi-asserted-by":"crossref","unstructured":"Uniprot Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506\u201315.","DOI":"10.1093\/nar\/gky1049"},{"key":"814_CR36","doi-asserted-by":"publisher","unstructured":"Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, Sidiropoulos K, Cook J, Gillespie M, Haw R, Loney F, May B, Milacic M, Rothfels K, Sevilla C, Shamovsky V, Shorser S, Varusai T, Weiser J, Wu G, Stein L, Hermjakob H, D\u2019Eustachio P. The reactome pathway knowledgebase. Nucleic Acids Res. 2019. https:\/\/doi.org\/10.1093\/nar\/gkz1031.","DOI":"10.1093\/nar\/gkz1031"},{"issue":"9","key":"814_CR37","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","volume":"35","author":"P Liu","year":"2014","unstructured":"Liu P, Fleete MS, Jing Y, Collie ND, Curtis MA, Waldvogel HJ, Faull RLM, Abraham WC, Zhang H. Altered arginine metabolism in Alzheimer\u2019s disease brains. Neurobiol Aging. 2014;35(9):1992\u20132003. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.013.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"814_CR38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/bpa.12392","volume":"27","author":"JS Miners","year":"2017","unstructured":"Miners JS, Clarke P, Love S. Clusterin levels are increased in Alzheimer\u2019s disease and influence the regional distribution of Abeta. Brain Pathol (Zurich, Switzerland). 2017;27(3):305\u201313.","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"issue":"1","key":"814_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029868","volume":"7","author":"M Bjorkqvist","year":"2012","unstructured":"Bjorkqvist M, Ohlsson M, Minthon L, Hansson O. Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer\u2019s disease. PLoS One. 2012;7(1):e29868. https:\/\/doi.org\/10.1371\/journal.pone.0029868.","journal-title":"PLoS One"},{"key":"814_CR40","doi-asserted-by":"publisher","first-page":"5828056","DOI":"10.1155\/2017\/5828056","volume":"2017","author":"D Juarez-Rebollar","year":"2017","unstructured":"Juarez-Rebollar D, Rios C, Nava-Ruiz C, Mendez-Armenta M. Metallothionein in brain disorders. Oxidative Med Cell Longev. 2017;2017:5828056.","journal-title":"Oxidative Med Cell Longev"},{"issue":"9","key":"814_CR41","first-page":"2476","volume":"24","author":"M Hokama","year":"2014","unstructured":"Hokama M, Oka S, Leon J, Ninomiya T, Honda H, Sasaki K, et al. Altered expression of diabetes-related genes in Alzheimer\u2019s disease brains: the Hisayama study. Cereb Cortex (New York, N.Y. : 1991). 2014;24(9):2476\u201388.","journal-title":"Cereb Cortex (New York, N.Y. : 1991)"},{"issue":"1","key":"814_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1091\/mbc.e06-04-0283","volume":"18","author":"T Muller","year":"2007","unstructured":"Muller T, Concannon CG, Ward MW, Walsh CM, Tirniceriu AL, Tribl F, et al. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell. 2007;18(1):201\u201310. https:\/\/doi.org\/10.1091\/mbc.e06-04-0283.","journal-title":"Mol Biol Cell"},{"issue":"9","key":"814_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044260","volume":"7","author":"SJ Kiddle","year":"2012","unstructured":"Kiddle SJ, Thambisetty M, Simmons A, Riddoch-Contreras J, Hye A, Westman E, Pike I, Ward M, Johnston C, Lupton MK, Lunnon K, Soininen H, Kloszewska I, Tsolaki M, Vellas B, Mecocci P, Lovestone S, Newhouse S, Dobson R, for the Alzheimers Disease Neuroimaging Initiative. Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS One. 2012;7(9):e44260. https:\/\/doi.org\/10.1371\/journal.pone.0044260.","journal-title":"PLoS One"},{"issue":"3","key":"814_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/01616412.2017.1281195","volume":"39","author":"Y Kitamura","year":"2017","unstructured":"Kitamura Y, Usami R, Ichihara S, Kida H, Satoh M, Tomimoto H, Murata M, Oikawa S. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer\u2019s disease. Neurol Res. 2017;39(3):231\u20138. https:\/\/doi.org\/10.1080\/01616412.2017.1281195.","journal-title":"Neurol Res"},{"issue":"41","key":"814_CR45","doi-asserted-by":"publisher","first-page":"E9687","DOI":"10.1073\/pnas.1811172115","volume":"115","author":"SK Baker","year":"2018","unstructured":"Baker SK, Chen ZL, Norris EH, Revenko AS, MacLeod AR, Strickland S. Blood-derived plasminogen drives brain inflammation and plaque deposition in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2018;115(41):E9687\u2013e9696. https:\/\/doi.org\/10.1073\/pnas.1811172115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"814_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-5956-12-5","volume":"12","author":"F Song","year":"2014","unstructured":"Song F, Poljak A, Kochan NA, Raftery M, Brodaty H, Smythe GA, Sachdev PS. Plasma protein profiling of mild cognitive impairment and Alzheimer\u2019s disease using iTRAQ quantitative proteomics. Proteome Sci. 2014;12(1):5. https:\/\/doi.org\/10.1186\/1477-5956-12-5.","journal-title":"Proteome Sci"},{"issue":"1","key":"814_CR47","doi-asserted-by":"publisher","first-page":"29078","DOI":"10.1038\/srep29078","volume":"6","author":"J Muenchhoff","year":"2016","unstructured":"Muenchhoff J, Poljak A, Thalamuthu A, Gupta VB, Chatterjee P, Raftery M, Masters CL, Morris JC, Bateman RJ, Fagan AM, Martins RN, Sachdev PS. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer\u2019s disease. Sci Rep. 2016;6(1):29078. https:\/\/doi.org\/10.1038\/srep29078.","journal-title":"Sci Rep"},{"issue":"8","key":"814_CR48","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/gps.4047","volume":"29","author":"M Noguchi","year":"2014","unstructured":"Noguchi M, Sato T, Nagai K, Utagawa I, Suzuki I, Arito M, Iizuka N, Suematsu N, Okamoto K, Kato T, Yamaguchi N, Kurokawa MS. Roles of serum fibrinogen alpha chain-derived peptides in Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2014;29(8):808\u201318. https:\/\/doi.org\/10.1002\/gps.4047.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"814_CR49","first-page":"152","volume":"3","author":"M Foote","year":"2012","unstructured":"Foote M, Zhou Y. 14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol. 2012;3(2):152\u201364.","journal-title":"Int J Biochem Mol Biol"},{"issue":"1\u20133","key":"814_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbamcr.2004.09.011","volume":"1742","author":"A Boom","year":"2004","unstructured":"Boom A, Pochet R, Authelet M, Pradier L, Borghgraef P, van Leuven F, Heizmann CW, Brion JP. Astrocytic calcium\/zinc binding protein S100A6 over expression in Alzheimer\u2019s disease and in PS1\/APP transgenic mice models. Biochim Biophys Acta. 2004;1742(1\u20133):161\u20138. https:\/\/doi.org\/10.1016\/j.bbamcr.2004.09.011.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"814_CR51","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-008-0373-3","volume":"115","author":"JH Power","year":"2008","unstructured":"Power JH, Asad S, Chataway TK, Chegini F, Manavis J, Temlett JA, et al. Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer\u2019s disease pathology. Acta Neuropathol. 2008;115(6):611\u201322. https:\/\/doi.org\/10.1007\/s00401-008-0373-3.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"814_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13195-017-0335-x","volume":"10","author":"FH Duits","year":"2018","unstructured":"Duits FH, Brinkmalm G, Teunissen CE, Brinkmalm A, Scheltens P, van der Flier WM, et al. Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer\u2019s disease. Alzheimers Res Ther. 2018;10(1):5.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"814_CR53","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/JAD-180905","volume":"68","author":"P Devanarayan","year":"2019","unstructured":"Devanarayan P, Devanarayan V, Llano DA. Identification of a simple and novel cut-point based cerebrospinal fluid and MRI signature for predicting Alzheimer\u2019s disease progression that reinforces the 2018 NIA-AA research framework. J Alzheimers Dis. 2019;68(2):537\u201350. https:\/\/doi.org\/10.3233\/JAD-180905.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"814_CR54","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1212\/WNL.0000000000006082","volume":"91","author":"S Janelidze","year":"2018","unstructured":"Janelidze S, Mattsson N, Stomrud E, Lindberg O, Palmqvist S, Zetterberg H, Blennow K, Hansson O. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease. Neurology. 2018;91(9):e867\u201377. https:\/\/doi.org\/10.1212\/WNL.0000000000006082.","journal-title":"Neurology"},{"issue":"1","key":"814_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3988\/jcn.2018.14.1.29","volume":"14","author":"J Shang","year":"2018","unstructured":"Shang J, Yamashita T, Fukui Y, Song D, Li X, Zhai Y, et al. Different associations of plasma biomarkers in Alzheimer\u2019s disease, mild cognitive impairment, vascular dementia, and ischemic stroke. J Clin Neurol (Seoul, Korea). 2018;14(1):29\u201334.","journal-title":"J Clin Neurol (Seoul, Korea)"},{"issue":"2","key":"814_CR56","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2174\/18715273113126660141","volume":"13","author":"J Zemva","year":"2014","unstructured":"Zemva J, Schubert M. The role of neuronal insulin\/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer\u2019s disease: possible therapeutic implications. CNS Neurol Disord Drug Targets. 2014;13(2):322\u201337. https:\/\/doi.org\/10.2174\/18715273113126660141.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1\u20132","key":"814_CR57","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jns.2015.09.344","volume":"358","author":"NE Anvar","year":"2015","unstructured":"Anvar NE, Saliminejad K, Ohadi M, Kamali K, Daneshmand P, Khorshid HR. Association between polymorphisms in Interleukin-16 gene and risk of late-onset Alzheimer\u2019s disease. J Neurol Sci. 2015;358(1\u20132):324\u20137. https:\/\/doi.org\/10.1016\/j.jns.2015.09.344.","journal-title":"J Neurol Sci"},{"issue":"4","key":"814_CR58","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3233\/JAD-2012-121378","volume":"33","author":"M Farkas","year":"2013","unstructured":"Farkas M, Keskitalo S, Smith DEC, Bain N, Semmler A, Ineichen B, Smulders Y, Blom H, Kulic L, Linnebank M. Hyperhomocysteinemia in Alzheimer\u2019s disease: the hen and the egg? J Alzheimers Dis. 2013;33(4):1097\u2013104. https:\/\/doi.org\/10.3233\/JAD-2012-121378.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"814_CR59","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.neurobiolaging.2006.08.003","volume":"28","author":"ML Selley","year":"2007","unstructured":"Selley ML. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer\u2019s disease. Neurobiol Aging. 2007;28(12):1834\u20139. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.08.003.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"814_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031501","volume":"7","author":"C Czech","year":"2012","unstructured":"Czech C, Berndt P, Busch K, Schmitz O, Wiemer J, Most V, Hampel H, Kastler J, Senn H. Metabolite profiling of Alzheimer\u2019s disease cerebrospinal fluid. PLoS One. 2012;7(2):e31501. https:\/\/doi.org\/10.1371\/journal.pone.0031501.","journal-title":"PLoS One"},{"issue":"9","key":"814_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1601576","volume":"3","author":"M Frenkel-Pinter","year":"2017","unstructured":"Frenkel-Pinter M, Shmueli MD, Raz C, Yanku M, Zilberzwige S, Gazit E, Segal D. Interplay between protein glycosylation pathways in Alzheimer\u2019s disease. Sci Adv. 2017;3(9):e1601576. https:\/\/doi.org\/10.1126\/sciadv.1601576.","journal-title":"Sci Adv"},{"key":"814_CR62","doi-asserted-by":"crossref","unstructured":"Lin CH, Yang HT, Lane HY. D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer\u2019s disease or mild cognitive impairment. Pharmacology, biochemistry, and behavior 2019; 185:172760.","DOI":"10.1016\/j.pbb.2019.172760"},{"key":"814_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2015.11.018","volume":"39","author":"JX Yin","year":"2016","unstructured":"Yin JX, Maalouf M, Han P, Zhao M, Gao M, Dharshaun T, Ryan C, Whitelegge J, Wu J, Eisenberg D, Reiman EM, Schweizer FE, Shi J. Ketones block amyloid entry and improve cognition in an Alzheimer\u2019s model. Neurobiol Aging. 2016;39:25\u201337. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.11.018.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"814_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.55","volume":"1","author":"M Ore\u0161i\u010d","year":"2011","unstructured":"Ore\u0161i\u010d M, Hy\u00f6tyl\u00e4inen T, Herukka S-K, Sysi-Aho M, Mattila I, Sepp\u00e4nan-Laakso T, Julkunen V, Gopalacharyulu PV, Hallikainen M, Koikkalainen J, Kivipelto M, Helisalmi S, L\u00f6tj\u00f6nen J, Soininen H. Metabolome in progression to Alzheimer\u2019s disease. Transl Psychiatry. 2011;1(12):e57. https:\/\/doi.org\/10.1038\/tp.2011.55.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"814_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12014-020-09285-8","volume":"17","author":"M Zhou","year":"2020","unstructured":"Zhou M, Haque RU, Dammer EB, Duong DM, Ping L, Johnson ECB, et al. Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Clin Proteom. 2020;17(1):1\u201314.","journal-title":"Clin Proteom"},{"issue":"3","key":"814_CR66","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1468-1331.2008.02059.x","volume":"15","author":"I Mateo","year":"2008","unstructured":"Mateo I, Llorca J, Infante J, Rodr\u00edguez-Rodr\u00edguez E, Berciano J, Combarros O. Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer\u2019s disease risk. Eur J Neurol. 2008;15(3):219\u201322. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02059.x.","journal-title":"Eur J Neurol"},{"issue":"6","key":"814_CR67","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20199356","volume":"16","author":"JM Bader","year":"2020","unstructured":"Bader JM, Geyer PE, M\u00fcller JB, Strauss MT, Koch M, Leypoldt F, Koertvelyessy P, Bittner D, Schipke CG, Incesoy EI, Peters O, Deigendesch N, Simons M, Jensen MK, Zetterberg H, Mann M. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease. Mol Syst Biol. 2020;16(6):e9356. https:\/\/doi.org\/10.15252\/msb.20199356.","journal-title":"Mol Syst Biol"},{"issue":"7","key":"814_CR68","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/brain\/awx132","volume":"140","author":"C George","year":"2017","unstructured":"George C, Gontier G, Lacube P, Fran\u00e7ois J-C, Holzenberger M, A\u00efd S. The Alzheimer\u2019s disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons. Brain. 2017;140(7):2012\u201327. https:\/\/doi.org\/10.1093\/brain\/awx132.","journal-title":"Brain"},{"issue":"1","key":"814_CR69","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1096\/fj.07-8309com","volume":"22","author":"Y Deng","year":"2008","unstructured":"Deng Y, Li B, Liu F, Iqbal K, Grundke-Iqbal I, Brandt R, Gong CX. Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease. FASEB J. 2008;22(1):138\u201345. https:\/\/doi.org\/10.1096\/fj.07-8309com.","journal-title":"FASEB J"},{"issue":"2","key":"814_CR70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3233\/JAD-151193","volume":"52","author":"I Cuchillo-Iba\u00f1ez","year":"2016","unstructured":"Cuchillo-Iba\u00f1ez I, Balmaceda V, Mata-Balaguer T, Lopez-Font I, S\u00e1ez-Valero J. Reelin in Alzheimer\u2019s disease, increased levels but impaired signaling: when more is less. J Alzheimers Dis. 2016;52(2):403\u201316. https:\/\/doi.org\/10.3233\/JAD-151193.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"814_CR71","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","volume":"15","author":"AR Morgan","year":"2019","unstructured":"Morgan AR, Touchard S, Leckey C, O\u2019Hagan C, Nevado-Holgado AJ, Barkhof F, et al. Inflammatory biomarkers in Alzheimer\u2019s disease plasma. Alzheimers Dement. 2019;15(6):776\u201387. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.007.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"814_CR72","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.trci.2019.11.001","volume":"5","author":"D Stamate","year":"2019","unstructured":"Stamate D, Kim M, Proitsi P, Westwood S, Baird A, Nevado-Holgado A, Hye A, Bos I, Vos SJB, Vandenberghe R, Teunissen CE, Kate MT, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, de Roeck E, Engelborghs S, Sleegers K, Bordet R, Ramit L, Kettunen P, Tsolaki M, Verhey F, Alcolea D, Ll\u00e9o A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Fr\u00f6lich L, Dobricic V, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Legido-Quigley C. A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. Alzheimers Dement (N Y). 2019;5(1):933\u20138. https:\/\/doi.org\/10.1016\/j.trci.2019.11.001.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"814_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acs.jproteome.8b00504","volume":"18","author":"JE van Eyk","year":"2019","unstructured":"van Eyk JE, Snyder MP. Precision medicine: role of proteomics in changing clinical management and care. J Proteome Res. 2019;18(1):1\u20136. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00504.","journal-title":"J Proteome Res"},{"issue":"11","key":"814_CR74","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/mds.28192","volume":"35","author":"I Markaki","year":"2020","unstructured":"Markaki I, Bergstr\u00f6m S, Tsitsi P, Remnest\u00e5l J, M\u00e5nberg A, Hertz E, Paslawski W, Sorjonen K, Uhl\u00e9n M, Mangone G, Carvalho S, Rascol O, Meissner WG, Magnin E, W\u00fcllner U, Corvol JC, Nilsson P, Svenningsson P. Cerebrospinal fluid levels of kininogen-1 indicate early cognitive impairment in Parkinson\u2019s disease. Mov Disord. 2020;35(11):2101\u20136. https:\/\/doi.org\/10.1002\/mds.28192.","journal-title":"Mov Disord"},{"issue":"5","key":"814_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/bib\/bbr042","volume":"12","author":"P Gaudet","year":"2011","unstructured":"Gaudet P, Livstone MS, Lewis SE, Thomas PD. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Brief Bioinform. 2011;12(5):449\u201362. https:\/\/doi.org\/10.1093\/bib\/bbr042.","journal-title":"Brief Bioinform"},{"issue":"2","key":"814_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1083\/jcb.200807155","volume":"185","author":"A Fejtova","year":"2009","unstructured":"Fejtova A, Davydova D, Bischof F, Lazarevic V, Altrock WD, Romorini S, Sch\u00f6ne C, Zuschratter W, Kreutz MR, Garner CC, Ziv NE, Gundelfinger ED. Dynein light chain regulates axonal trafficking and synaptic levels of Bassoon. J Cell Biol. 2009;185(2):341\u201355. https:\/\/doi.org\/10.1083\/jcb.200807155.","journal-title":"J Cell Biol"},{"key":"814_CR77","doi-asserted-by":"publisher","unstructured":"Meng X, McGraw CM, Wang W, Jing J, Yeh S-Y, Wang L, et al. Neurexophilin4 is a selectively expressed \u03b1-neurexin ligand that modulates specific cerebellar synapses and motor functions. Elife. 2019;8. https:\/\/doi.org\/10.7554\/eLife.46773.","DOI":"10.7554\/eLife.46773"},{"issue":"2","key":"814_CR78","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","volume":"35","author":"L Whiley","year":"2014","unstructured":"Whiley L, Sen A, Heaton J, Proitsi P, Garc\u00eda-G\u00f3mez D, Leung R, Smith N, Thambisetty M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Lovestone S, Legido-Quigley C, AddNeuroMed Consortium. Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(2):271\u20138. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.08.001.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"814_CR79","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.nbd.2011.03.012","volume":"43","author":"HD VanGuilder","year":"2011","unstructured":"VanGuilder HD, Farley JA, Yan H, van Kirk CA, Mitschelen M, Sonntag WE, et al. Hippocampal dysregulation of synaptic plasticity-associated proteins with age-related cognitive decline. Neurobiol Dis. 2011;43(1):201\u201312. https:\/\/doi.org\/10.1016\/j.nbd.2011.03.012.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"814_CR80","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3233\/JAD-150036","volume":"46","author":"W Jongbloed","year":"2015","unstructured":"Jongbloed W, van Dijk KD, Mulder SD, van de Berg WDJ, Blankenstein MA, van der Flier W, Veerhuis R. Clusterin levels in plasma predict cognitive decline and progression to Alzheimer\u2019s disease. J Alzheimers Dis. 2015;46(4):1103\u201310. https:\/\/doi.org\/10.3233\/JAD-150036.","journal-title":"J Alzheimers Dis"},{"key":"814_CR81","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnagi.2019.00025","volume":"11","author":"BM Bettcher","year":"2019","unstructured":"Bettcher BM, Neuhaus J, Wynn MJ, Elahi FM, Casaletto KB, Saloner R, et al. Increases in a pro-inflammatory chemokine, MCP-1, are related to decreases in memory over time. Front Aging Neurosci. 2019;11:25.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"814_CR82","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3233\/JAD-2012-120820","volume":"32","author":"M Cortes-Canteli","year":"2012","unstructured":"Cortes-Canteli M, Zamolodchikov D, Ahn HJ, Strickland S, Norris EH. Fibrinogen and altered hemostasis in Alzheimer\u2019s disease. J Alzheimers Dis. 2012;32(3):599\u2013608. https:\/\/doi.org\/10.3233\/JAD-2012-120820.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"814_CR83","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-4933-9-20","volume":"9","author":"S Catricala","year":"2012","unstructured":"Catricala S, Torti M, Ricevuti G. Alzheimer disease and platelets: how\u2019s that relevant. Immun Ageing. 2012;9(1):20. https:\/\/doi.org\/10.1186\/1742-4933-9-20.","journal-title":"Immun Ageing"},{"key":"814_CR84","doi-asserted-by":"crossref","unstructured":"Wesenhagen KEJ, Teunissen CE, Visser PJ, Tijms BM. Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer\u2019s disease: a literature review. Crit Rev Clin Lab Sci. 2020;57(2):86-98.","DOI":"10.1080\/10408363.2019.1670613"},{"issue":"1","key":"814_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209573","volume":"14","author":"MB Huynh","year":"2019","unstructured":"Huynh MB, Ouidja MO, Chantepie S, Carpentier G, Ma\u00efza A, Zhang G, Vilares J, Raisman-Vozari R, Papy-Garcia D. Glycosaminoglycans from Alzheimer\u2019s disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau. PLoS One. 2019;14(1):e0209573. https:\/\/doi.org\/10.1371\/journal.pone.0209573.","journal-title":"PLoS One"},{"issue":"1","key":"814_CR86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-150544","volume":"49","author":"SV Ovsepian","year":"2016","unstructured":"Ovsepian SV, O\u2019Leary VB. Neuronal activity and amyloid plaque pathology: an update. J Alzheimers Dis. 2016;49(1):13\u20139. https:\/\/doi.org\/10.3233\/JAD-150544.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"814_CR87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2174\/157015906776359531","volume":"4","author":"F Pe\u00f1a","year":"2006","unstructured":"Pe\u00f1a F, Guti\u00e9rrez-Lerma A, Quiroz-Baez R, Arias C. The role of beta-amyloid protein in synaptic function: implications for Alzheimer\u2019s disease therapy. Curr Neuropharmacol. 2006;4(2):149\u201363. https:\/\/doi.org\/10.2174\/157015906776359531.","journal-title":"Curr Neuropharmacol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00814-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-021-00814-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00814-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T05:12:04Z","timestamp":1617253924000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00814-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["814"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00814-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-130933\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethics committee of Vaud, Switzerland, approved this study (No. 171\/2013), and all participants or their legal representatives provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JP received consultation honoraria from Nestle Institute of Health Sciences, Innovation Campus, EPFL, Lausanne, Switzerland, Ono Pharma, and from Fujirebio Europe. The other authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}